Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2025-05-07 AGM Information
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Resolutions at the Annual General Meeting in Medivir on 7 May 2025
AGM Information Classification · 99% confidence The document explicitly states it contains the 'Resolutions at the Annual General Meeting in Medivir on 7 May 2025'. It details decisions made regarding profit distribution, remuneration, election of the board, and authorization to issue new shares, which are typical outcomes of an AGM. This directly corresponds to the 'AGM Information' category.
2025-05-07 English
Beslut vid årsstämma i Medivir den 7 maj 2025
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämma i Medivir den 7 maj 2025" (Decisions at the Annual General Meeting in Medivir on May 7, 2025). It explicitly details the resolutions passed by the general meeting, including the approval of financial statements, remuneration decisions, election of the board and auditor, and authorization for share issuance. These are the core components of an Annual General Meeting (AGM) outcome report. Therefore, the appropriate classification is AGM-R (AGM Information).
2025-05-07 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Medivir AB covering the period January to March 2025. It contains detailed financial summaries (EBITDA, net sales, cash flow), management commentary, and operational updates on clinical trials and pipeline projects. As it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-04-29 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2025'. It contains detailed financial summaries, including net turnover, EBITDA, earnings per share, and cash flow for the specified quarter. It also includes a CEO's message, business updates, and project status reports. As it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-04-29 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by N.G.L. Förvaltning AB in Medivir Aktiebolag, specifically noting that the shareholder has crossed the 5% threshold of voting rights. This falls under the category of a Major Shareholding Notification (MRQ).
2025-04-10 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing submitted to the Swedish Financial Supervisory Authority (Finansinspektionen) regarding a change in shareholding. It details a 'flaggningsmeddelande' (flagging notification) where Avanza Bank Holding AB reports a sale of shares in Medivir Aktiebolag, resulting in their ownership falling below a specific threshold. This fits the definition of a Major Shareholding Notification (MRQ).
2025-04-07 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.